• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

印度晚期非小细胞肺癌治疗共识声明：一线、维持及二线治疗

Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line.

出版信息

Indian J Cancer. 2017 Jan-Mar;54(1):89-103. doi: 10.4103/ijc.IJC_136_17.

DOI:10.4103/ijc.IJC_136_17
PMID:29199671
Abstract

The management of advanced nonsmall cell lung cancer (NSCLC) patients is becoming complex with the identification of driver mutations and targeted therapies. The expert group of academic medical oncologists used data from published literature, practical experience to arrive at practical consensus recommendations to treat advanced NSCLC for use by the community oncologists.

摘要

随着驱动基因突变的识别和靶向治疗的出现，晚期非小细胞肺癌（NSCLC）患者的管理变得复杂起来。学术肿瘤内科专家小组利用已发表文献的数据和实践经验，得出了针对晚期NSCLC治疗的实用共识建议，供社区肿瘤医生使用。

相似文献

1
Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line.印度晚期非小细胞肺癌治疗共识声明：一线、维持及二线治疗
Indian J Cancer. 2017 Jan-Mar;54(1):89-103. doi: 10.4103/ijc.IJC_136_17.
2
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line - Indian consensus statement update.晚期非小细胞肺癌的治疗：一线、维持及二线治疗——印度共识声明更新
South Asian J Cancer. 2019 Jan-Mar;8(1):1-17. doi: 10.4103/sajc.sajc_227_18.
3
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.转移性非小细胞肺癌：病理和分子检测共识，一线、二线和三线治疗：1 次 ESMO 肺癌共识会议；2010 年卢加诺。
Ann Oncol. 2011 Jul;22(7):1507-1519. doi: 10.1093/annonc/mdr150. Epub 2011 May 2.
4
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.亚洲晚期非小细胞肺癌的一线全身治疗：2009年亚洲肿瘤学峰会共识声明
Lancet Oncol. 2009 Nov;10(11):1102-10. doi: 10.1016/S1470-2045(09)70238-4.
5
A paradigm shift in the treatment of advanced non-small cell lung cancer.晚期非小细胞肺癌治疗的范式转变。
Am J Med Sci. 2012 Aug;344(2):147-50. doi: 10.1097/MAJ.0b013e318246e1b8.
6
Can a decisional algorithm be used in first-line treatment of advanced nonsmall cell lung cancer?决策算法能否用于晚期非小细胞肺癌的一线治疗？
Curr Opin Oncol. 2010 Mar;22(2):77-8. doi: 10.1097/CCO.0b013e328335011d.
7
Maintenance therapy: a new treatment paradigm in advanced nonsmall-cell lung cancer.维持治疗：晚期非小细胞肺癌的一种新治疗模式。
Curr Opin Oncol. 2013 Mar;25(2):105-6. doi: 10.1097/CCO.0b013e32835ca1c3.
8
[Impact of histology on efficacy of pemetrexed: pemetrexed in second-line setting and as maintenance therapy after first-line treatment in Chinese patients with advanced NSCLC].[组织学对培美曲塞疗效的影响：中国晚期非小细胞肺癌患者二线应用培美曲塞及一线治疗后维持治疗的情况]
Zhonghua Zhong Liu Za Zhi. 2014 Jan;36(1):29-33.
9
Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer.晚期非小细胞肺癌患者的延长治疗策略。
J Clin Oncol. 2010 Dec 1;28(34):5116-23. doi: 10.1200/JCO.2010.30.7074. Epub 2010 Nov 1.
10
[Fourth-line and beyond therapy in advanced non-small cell lung cancer: a retrospective analysis].[晚期非小细胞肺癌的四线及后续治疗：一项回顾性分析]
Zhongguo Fei Ai Za Zhi. 2014 Dec;17(12):839-44. doi: 10.3779/j.issn.1009-3419.2014.12.03.

引用本文的文献

1
Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancer.单 TKI 与 TKI 联合局部巩固性放疗治疗驱动基因阳性寡转移非小细胞肺癌的 II 期随机对照试验方案。
BMJ Open. 2021 Feb 15;11(2):e041345. doi: 10.1136/bmjopen-2020-041345.
2
First-line management of metastatic non-small cell lung cancer: An Indian perspective.转移性非小细胞肺癌的一线管理：印度视角
South Asian J Cancer. 2019 Apr-Jun;8(2):73-79. doi: 10.4103/sajc.sajc_294_18.